Health Condition 1: C910- Acute lymphoblastic leukemia [ALL] Health Condition 2: C920- Acute myeloblastic leukemia Health Condition 3: C926- Acute myeloid leukemia with 11q23-abnormality Health Condition 4: C92A- Acute myeloid leukemia with multilineage dysplasia Health Condition 5: C925- Acute myelomonocytic leukemia Health Condition 6: C924- Acute promyelocytic leukemia
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1)Adult patients of age 18 years or above 2)Newly diagnosed patients with AML/ALL attending the Adult Haemato- Oncology Joint Clinic at Tata Memorial Hospital and those who have not received any prior cancer directed treatment 3)Planned and expected to receive induction chemotherapy with curative intent 4)Patient has been informed of diagnosis and treatment 5)Able to communicate in English/Marathi/Hindi/Bengali 6)Performance Score of less than or equal to 3 on Eastern Cooperative Oncology Group(ECOG) scale 7)Able to give a written informed consent
Exclusion criteria
Exclusion criteria: 1)Patients who are upfront best supportive care and are planned for treatment with palliative intent 2)Patients with unstable medical conditions , oncological emergencies or psychiatric emergencies. 3)Any form of intellectual disability or cognitive impairment defined as a Mini Mental Status Examination Score less than 24.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcomes: i)Identification of needs and major domains of needs in adult patients with AML/ALL using Functional Assessment of Cancer Therapy-Leukaemia(FACT- Leu) scale and subscales at baseline and at 4 weeks following induction chemotherapy. ii)To measure the symptom burden specific to this patient population using FACT- Leu subscales at baseline and at 4 weeks. Timepoint: Baseline and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To find out the factors associated with the needs and symptom profile in this patient population as assessed by the variation in the FACT-Leu subscale scores and total scores with respect to sociodemographic and clinical characteristics at baseline and at 4 weeks following induction chemotherapy. Timepoint: Baseline and 4 weeks | — |
Countries
India
Contacts
Public ContactDr Jayita K Deodhar
Tata Memorial Hospital
Outcome results
None listed